Pacira BioSciences PCRX
$ 17.64
1.5%
Quarterly report 2024-Q3
added 11-06-2024
Pacira BioSciences Cash Flow 2011-2024 | PCRX
Annual Cash Flow Pacira BioSciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
155 M | 145 M | 126 M | 77 M | 70.5 M | 48.9 M | 17.8 M | - | - | - | - | - | - |
Depreciation & Amortization |
75.6 M | 91.5 M | 28.5 M | 19.9 M | 19.6 M | 13.2 M | 13.8 M | 12.9 M | 11.5 M | 10 M | 5.75 M | 5.65 M | 4.31 M |
Accounts Payables |
15.7 M | 15.2 M | 10.5 M | 10.4 M | 12.8 M | 14.4 M | 14.7 M | 7.51 M | 8.74 M | 6.76 M | 3.07 M | 2.57 M | 3.44 M |
Accounts Receivables |
106 M | 98.4 M | 96.3 M | 53 M | 47.5 M | 38 M | 31.7 M | 29.9 M | 25.9 M | 22.4 M | 14.6 M | 4.35 M | 2.11 M |
Total Inventories |
104 M | 96.1 M | 98.6 M | 64.6 M | 58.3 M | 48.6 M | 41.4 M | 31.3 M | 61.6 M | 29.3 M | 15.6 M | 12.1 M | 1.24 M |
All numbers in USD currency
Quarterly Cash Flow Pacira BioSciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 49.1 M | - | - | - | 19.1 M | - | 103 M | - | 30.8 M | - | 103 M | - | 12.1 M | - | 30.4 M | -9.42 M | 6.21 M | - | 44.6 M | 26.3 M | 3.5 M | - | 27.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
6 M | 4.5 M | 18.4 M | - | 4.1 M | 4.7 M | 19.6 M | - | 5.8 M | 6.5 M | 20 M | - | 15.5 M | 2.9 M | 4.85 M | - | 14.8 M | 9.81 M | 4.82 M | - | 14.5 M | 8.88 M | 3.6 M | - | 9.11 M | 5.61 M | 2.76 M | - | 10.2 M | 6.81 M | 3.1 M | - | 9.66 M | 6.38 M | 3.16 M | - | 8.36 M | 5.53 M | 2.74 M | 10 M | 7.33 M | 4.94 M | 2.6 M | - | 4.05 M | 2.72 M | 1.43 M | - | 4.2 M | - | 1.38 M | - | 400 K | 400 K | 990 K |
Accounts Payables |
19.4 M | 18.7 M | 8.98 M | 15.7 M | 16.5 M | 24.2 M | 17.3 M | 15.2 M | 12.9 M | - | 14.8 M | 10.5 M | 7.9 M | 12.2 M | 9.11 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 7.51 M | 7.51 M | 7.51 M | 7.51 M | 8.74 M | 8.74 M | 8.74 M | 8.74 M | 6.76 M | 6.76 M | 6.76 M | 6.76 M | 3.07 M | 3.07 M | 3.07 M | 3.07 M | 2.57 M | 2.57 M | 2.57 M | 2.57 M | 3.44 M | 3.44 M | 3.44 M | 3.44 M |
Accounts Receivables |
101 M | 105 M | 102 M | 106 M | 97 M | 99.1 M | 93.2 M | 98.4 M | 93.5 M | - | 92.1 M | 96.3 M | 50 M | 68.4 M | 52.6 M | 53 M | 53 M | 53 M | 53 M | 47.5 M | 47.5 M | 47.5 M | 47.5 M | 38 M | 38 M | 38 M | 38 M | 31.7 M | 31.7 M | 31.7 M | 31.7 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 25.9 M | 25.9 M | 25.9 M | 25.9 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 4.35 M | 4.35 M | 4.35 M | 4.35 M | 2.11 M | 2.11 M | 2.11 M | 2.11 M |
Total Inventories |
112 M | 103 M | 96.8 M | 104 M | 96.5 M | 92.1 M | 93 M | 96.1 M | 96.8 M | - | 104 M | 98.6 M | 67.2 M | 65.3 M | 64.6 M | 64.6 M | 64.6 M | 64.6 M | 64.6 M | 58.3 M | 58.3 M | 58.3 M | 58.3 M | 48.6 M | 48.6 M | 48.6 M | 48.6 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 61.6 M | 61.6 M | 61.6 M | 61.6 M | 29.3 M | 29.3 M | 29.3 M | 29.3 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 1.24 M | 1.24 M | 1.24 M | 1.24 M |
All numbers in USD currency